15 reports of this reaction
1.3% of all MEXILETINE HYDROCHLORIDE reports
#13 most reported adverse reaction
CONTUSION is the #13 most commonly reported adverse reaction for MEXILETINE HYDROCHLORIDE, manufactured by ANI Pharmaceuticals, Inc.. There are 15 FDA adverse event reports linking MEXILETINE HYDROCHLORIDE to CONTUSION. This represents approximately 1.3% of all 1,120 adverse event reports for this drug.
Patients taking MEXILETINE HYDROCHLORIDE who experience contusion should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
CONTUSION is a less commonly reported adverse event for MEXILETINE HYDROCHLORIDE, but still significant enough to appear in the safety profile.
In addition to contusion, the following adverse reactions have been reported for MEXILETINE HYDROCHLORIDE:
The following drugs have also been linked to contusion in FDA adverse event reports:
CONTUSION has been reported as an adverse event in 15 FDA reports for MEXILETINE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
CONTUSION accounts for approximately 1.3% of all adverse event reports for MEXILETINE HYDROCHLORIDE, making it a notable side effect.
If you experience contusion while taking MEXILETINE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.